# SUCCESS (SelUtion, Safety, effiCaCy, hEalth economicS and promS) PTA Study

Study · id `cardio:ct-nct04776434` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04776434](<https://clinicaltrials.gov/study/NCT04776434>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT04776434

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 723 participants.

## Technical summary

Registry record NCT04776434. Allocation not applicable; no masking; primary purpose treatment. Start 2021-02-08 (actual); primary completion 2024-11-10 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 723 participants (enrolled count; ClinicalTrials.gov record NCT04776434, source copy `cardio:ctgov-nct04776434-2026-11-06`, retrieved 2026-11-18)
- Started: 2021-02-08 (actual) (ClinicalTrials.gov record NCT04776434, source copy `cardio:ctgov-nct04776434-2026-11-06`, retrieved 2026-11-18)
- Primary completion: 2024-11-10 (actual) (ClinicalTrials.gov record NCT04776434, source copy `cardio:ctgov-nct04776434-2026-11-06`, retrieved 2026-11-18)
- Completion: 2028-12-31 (anticipated) (ClinicalTrials.gov record NCT04776434, source copy `cardio:ctgov-nct04776434-2026-11-06`, retrieved 2026-11-18)
- Countries: Argentina; Germany; Greece; Netherlands; Singapore; Slovakia; Switzerland; United Kingdom (ClinicalTrials.gov record NCT04776434, source copy `cardio:ctgov-nct04776434-2026-11-06`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04776434-2026-11-06`, retrieved 2026-11-18)

## The registry's words

- Brief title: SUCCESS (SelUtion, Safety, effiCaCy, hEalth economicS and promS) PTA Study
- Acronym: SUCCESS PTA
- Condition: Peripheral Artery Disease
- Intervention (Device): SELUTION SLR™ (Sustained Limus Release) drug eluting balloon (DEB)
- Lead sponsor: M.A. Med Alliance S.A.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: M.A. Med Alliance S.A. (`cardio:org-m-a-med-alliance-s-a`)

## Provenance

Content hash: 7b21f6a525f2ab311ba79d457b2fa5b68d2e47f39d5f6fc69a2768b5b71c285c
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
